Fomitopsis cajanderi

Fomitopsis cajanderi (Rosy Conk): A Reference Article on Identity, Bioactive Constituents, Traditional Use, and Scientific Evidence

1. Identity, Nomenclature, and Taxonomy

1.1 Scientific Names and Synonymy

Fomitopsis cajanderi is the name under which this species has been most widely known in the scientific and supplement literature. However, its currently accepted taxonomic name—as indexed by Index Fungorum, NCBI, and the Catalogue of Life—is Rhodofomes cajanderi (P. Karst.) B.K. Cui, M.L. Han & Y.C. Dai (2016). This reclassification was formalized in 2016, placing the species under the genus Rhodofomes Kotl. & Pouzar, with the earlier designation Fomitopsis cajanderi (P. Karst.) Kotl. & Pouzar (1957) now treated as a synonym.

Additional historical synonyms recognized in the GBIF database include Fomes cajanderi P. Karst., Fomes subroseus (Weir) Overh., Fomitopsis roseozonata (Lloyd) S. Ito, Fomitopsis subrosea (Weir) Bondartsev & Singer, Polystictus mimicus (P. Karst.) Sacc. & Trotter, Pycnoporus mimicus P. Karst., Trametes roseozonata Lloyd, Trametes subrosea Weir, and Ungulina subrosea (Weir) Murashk.

The species epithet cajanderi commemorates Aimo Cajander, an early 1900s ecologist, forester, and three-time prime minister of Finland. The common name "rosy conk" refers to the fungus's distinctively colored pore surface. In Chinese, the organism is known as 卡氏擬層孔菌.

The ongoing nomenclatural debate surrounding this species reflects broader taxonomic instability in the family. According to Nobles (1971), Fomitopsis cajanderi was closely related to species of Daedalea, sharing several important morphological characters. After Nobles' view, Donk (1974) suggested the removal of F. cajanderi from Fomitopsis and its inclusion into Daedalea or a related group. A 2024 phylogenomics study published in Studies in Mycology proposed an alternative large-genus concept, arguing in favour of distinguishing only three genera in Fomitopsidaceae (Anthoporia, Antrodia, and Fomitopsis), under which Fomitopsis would become a large genus of 128 accepted species containing almost all former Fomitopsis spp. and most species formerly placed in Antrodia, Daedalea, and Laccocephalum.

1.2 Full Taxonomic Classification

The full taxonomic placement of Fomitopsis cajanderi (in its traditional classification) is: Domain: Eukarya; Kingdom: Fungi; Phylum: Basidiomycota; Subphylum: Agaricomycotina; Class: Agaricomycetes; Order: Polyporales; Family: Fomitopsidaceae; Genus: Fomitopsis. Under the reclassification accepted by NCBI, the species is assigned to the genus Rhodofomes within the family Fomitopsidaceae, Order Polyporales.

1.3 Physical Characteristics and Natural Source

The fungus is a perennial shelf (bracket) fungus. It may be identified by its small-to-medium-sized, fleshy, tough fruit-body with a downy or crust-like top, growing to around 3–10 cm wide. The top surface is pink becoming grey, brown, or black with a clear margin; the inside of the conk and the underside are a rosy pink colour. The body is rigid and can grow up to 1 cm thick. There are 3–5 round pores per millimeter. It produces a whitish spore print. It is classified as inedible.

Fruiting bodies are saprotrophic on dead conifer wood and parasitic on living conifers, and are rarely found on hardwoods. The spores are smooth and allantoid, measuring 5.5–7.0 × 1.5–2.0 µm, with an off-white spore print. Habitat is primarily on conifer wood, though specimens from broad-leaved trees have been documented in China (He et al., 2003; 2006).

In Western North America, F. cajanderi is often found on Douglas-fir. Distribution is described as widespread, occurring across North American conifer forests. It is widespread in western North America, with more prevalence in southern climates. It is a widely distributed species of bracket fungus, commonly known as the rosy conk due to its rose-colored pore surface; it causes a disease called brown pocket rot in various conifer species.

1.4 Ecological Role

Fomitopsis is a worldwide brown-rot fungal genus of Polyporales, which grows on different gymnosperm and angiosperm trees and has important ecological functions and economic values. It is the type genus of Fomitopsidaceae Jülich. Species in Fomitopsis cause a brown rot and play an important role in the degradation and reduction of forest ecosystems. As brown-rot fungi, members of the genus primarily grow on conifers and are characterized by their ability to degrade wood polysaccharides while partially modifying lignin, leading to wood shrinkage and brown discoloration.

1.5 Common Preparations and Commercial Forms

Historically, members of the Fomitopsis genus have played an important role in traditional medicine among indigenous peoples; while direct historical records of F. cajanderi specifically are limited, its close relatives have been employed in teas, tinctures, and topical applications to promote healing and vitality. In the scientific literature reviewed, the fruiting body is the part predominantly used. Preparations studied include hot ethanol extracts made via 2-hour Soxhlet extraction of the fruiting body in ethanol using a cold finger condenser, and hot aqueous extracts made via 2-hour decoction in water at 100°C. No standardized commercial supplement monograph or pharmacopoeial specification for F. cajanderi was identified in authoritative databases as of the searches conducted.

2. Traditional and Historical Use

2.1 Indigenous North American Use

Fomitopsis cajanderi has a history of use in traditional medicine, particularly among Indigenous peoples of North America, where it was valued for its potential health-promoting properties, especially for antimicrobial and wound-healing abilities. Native American tribes would sometimes apply dried or powdered F. cajanderi directly to wounds and cuts, leveraging its presumed antiseptic qualities to prevent infection and promote faster healing.

Beyond topical applications, infusions and decoctions made from the fruiting bodies were occasionally consumed to address various ailments, including respiratory issues such as coughs and sore throats. Some traditions employed it as a mild digestive aid and general tonic, supporting overall vitality and resilience against common illnesses.

It is important to note that direct historical records of Fomitopsis cajanderi specifically are limited, and much of the attributed traditional use is extrapolated from the broader Fomitopsis genus, whose close relatives have been employed in teas, tinctures, and topical applications.

2.2 Broader Genus-Level Traditional Context

Traditionally valued by indigenous cultures, species of Fomitopsis have been used for treating headache, nausea, and liver problems, as well as serving as haemostatics and anti-inflammatory agents due to their astringent effects. They were also employed for anti-fatigue, immune enhancement, cancer treatment, and as a styptic, antiseptic, and pain reliever across various regions, owing to the diverse bioactive compounds they produce (Grienke et al., 2014).

Initially recognized for their role in wood decomposition, these fungi are now celebrated as a rich source of bioactive compounds with significant therapeutic applications. Accounts from related species in the genus suggest a long history of polypore use in diverse cultures; however, the peer-reviewed ethnobotanical record directly attributing specific medicinal preparations specifically to F. cajanderi — as distinguished from related taxa — is sparse, and caution is warranted in attributing genus-level traditions specifically to this species.

3. Key Constituents and Active Compounds

3.1 Overview of Bioactive Secondary Metabolites

Members of the genus Fomitopsis are medicinal mushrooms and a rich source of bioactive compounds with significant pharmacological and biotechnological potential. These organisms produce secondary metabolites including polysaccharides, terpenoids, and phenolic compounds. These compounds exhibit antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory properties, with promising applications in cancer therapy, cardiovascular health, and immune modulation.

Advances in analytical techniques have revealed a wide range of pharmacologically active compounds, including polysaccharides, terpenoids, phenolic compounds, and secondary metabolites, all of which contribute to their ecological functions and therapeutic potential.

3.2 Fomlactones: Species-Specific Novel Triterpenoids

The most chemically distinctive research specific to F. cajanderi concerns the isolation of novel lactone-type triterpenoids. A study of secondary metabolites from F. cajanderi led to the isolation of three novel acetal lactones named fomlactones A, B, and C from the neutral ether extracts (He et al., 2003). Investigation of the neutral ether extracts of the fungus led to the isolation of three novel ketal lactones named fomlactones A (1), B (2), and C (3). These compounds were identified by analysis of IR, HRMS, CD, and 1D and 2D NMR data. The structure of fomlactone C (3) was confirmed by X-ray diffraction analysis.

Fomlactones A–C from Fomes cajanderi contain a 12,23-epoxy ring together with a 26,23-lactone (He et al., 2003). These compounds have been shown to possess interesting biological activities, including anti-inflammatory activity.

3.3 Lanostane Triterpenoids (24-Methylene-Lanostane Series)

The medicinal properties of the Fomitopsis genus originate substantially from triterpenoids, especially lanostane derivatives. The 24-methylene-lanostane triterpenes have been isolated from several Fomitopsis species, including Fomes cajanderi (synonym: Fomitopsis cajanderi) (He et al., 2003). This type of triterpenoids has demonstrated antimicrobial, cytotoxic, anti-inflammatory, and trypanocidal activity.

Fungal species of the Polyporaceae are known to produce 24-methyl-lanostanes with a carboxyl group at C-26, some of which possess a carboxyacetoxyl group at C-3. Fomlactones A–C from Fomes cajanderi contain a 12,23-epoxy ring together with a 26,23-lactone. This class of triterpenoids has been shown to possess anti-inflammatory, antimicrobial, anti-HIV, and DNA polymerase and DNA topoisomerase inhibitory activity.

3.4 Polysaccharides, Including Beta-Glucans

The hot aqueous extract of F. cajanderi, while not cytotoxic to MCF7 cells, was found to contain beta-glucans, which inhibited TNF secretion by LPS-stimulated U-937 cells in a concentration-dependent manner. The immunomodulatory and antitumour activities of fungal polysaccharides are generally associated with β-glucans and their derivatives. The triple helical conformation of β-glucans and the presence of hydrophilic groups located on the outer surface of the triple helix are regarded as important structural features for their biological immunostimulatory activity. No structural characterization specific to F. cajanderi beta-glucans beyond their detection in aqueous extracts was identified in the peer-reviewed literature reviewed.

3.5 Other Compound Classes

Scientific interest in Fomitopsis cajanderi has grown due to its reported content of bioactive compounds such as polysaccharides, phenolics, and terpenoids. In related Fomitopsis species, ergosterol (a major fungal sterol) and a variety of phenolic acids have also been characterized. No peer-reviewed study had, as of the literature reviewed, conducted a full phytochemical profiling of F. cajanderi comparable in breadth to work done on F. betulina or F. pinicola.

4. Mechanisms of Action

4.1 Cytotoxicity and Apoptosis Induction

Hot ethanol and aqueous extracts of F. cajanderi were studied for their cytotoxic effects on human cancer cell lines and modulation of TNF secretion. The ethanol extract exhibited concentration-dependent cytotoxicity against MCF7 and U-937 cells, while the aqueous extract was non-cytotoxic to MCF7 cells but inhibited TNF secretion in LPS-stimulated U-937 cells due to its beta-glucan content. These results indicate the potential of F. cajanderi extracts as novel adjunctive anti-cancer and anti-inflammatory agents (Wenner et al., 2021).

The differential tumoricidal action—with the ethanol fraction (containing triterpenoids) being cytotoxic while the aqueous fraction (containing polysaccharides) predominantly modulated immune signaling—is consistent with the broader genus-level mechanism proposed in the literature: while polysaccharides stimulate an immune response, triterpenes directly induce cancer cell apoptosis.

4.2 TNF Modulation and Immunomodulation

Effects of the aqueous extract on TNF secretion by PMA-differentiated, LPS-stimulated U-937 cells were determined by TNF ELISA. Glycosyl content and linkage analysis of the aqueous extract were assessed by the Complex Carbohydrate Research Center (Athens, Georgia, USA). The hot ethanol extract induced concentration-dependent cytotoxicity of MCF7 and U-937 cells, with stronger U-937 tumoricidal effects. The hot aqueous extract was not cytotoxic to MCF7 cells, but had cytotoxic effects on undifferentiated U-937 cells at high concentrations. The aqueous extract, found to contain beta-glucans, inhibited TNF secretion by LPS-stimulated U-937 cells in a concentration-dependent manner.

4.3 Anti-Inflammatory Mechanisms (Genus Level)

For Fomitopsis genus triterpenoids broadly, anti-inflammatory activities have been evaluated by estimating their effect on production of nitric oxide (NO) and prostaglandin E2 (PGE2) in LPS-stimulated RAW264.7 macrophages, as well as on expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Compounds from this series inhibited NO production and iNOS expression in LPS-stimulated RAW264.7 cells; among those studied, one compound exerted the highest inhibitory activity and reduced PGE2 levels via downregulation of COX-2 protein expression. These mechanisms have not been directly confirmed in F. cajanderi-specific experimental studies but are inferred from the closely related lanostane triterpenoids isolated from F. cajanderi.

5. Scientific Evidence by Area of Use

5.1 Anticancer and Cytotoxic Activity

Evidence level: Preclinical (in vitro only); no human clinical trials.

The primary direct study of F. cajanderi for anticancer effects is a 2021 conference abstract published in The Journal of Immunology by Wenner, Froehlich, and Sitkoff. This study aimed to determine if hot ethanol and aqueous extracts from the Fomitopsis cajanderi mushroom species are cytotoxic to human cancer cell lines and modulate TNF secretion by human monocytes (Wenner CA et al., J Immunol 206(1_Supplement):29.10, 2021).

Human MCF7 mammary adenocarcinoma and U-937 histiocytic lymphoma cells were treated with increasing concentrations of extract or solvent controls and were assessed for cytotoxicity by XTT colorimetric assay. Effects of the aqueous extract on TNF secretion by PMA-differentiated, LPS-stimulated U-937 cells were determined by TNF ELISA. Glycosyl content and linkage analysis of the aqueous extract were assessed by the Complex Carbohydrate Research Center.

Hot ethanol and aqueous F. cajanderi extracts showed differential tumoricidal actions on human cancer cells. The ethanol extract was cytotoxic to the human cancer cells tested. The aqueous extract contained beta-glucans reported to be immunomodulatory. The aqueous extract inhibited U-937 TNF secretion. These results warrant further research of F. cajanderi extracts as novel adjunctive anti-cancer and anti-inflammatory agents.

Limitations: This work is a conference abstract rather than a full peer-reviewed primary research article, was conducted exclusively in cell culture (in vitro), and did not include animal or human subjects. No dose or concentration data have been published in a retrievable full-text peer-reviewed form. The work should therefore be considered hypothesis-generating at this stage. No clinical trials involving F. cajanderi were identified in the available literature.

An earlier inquiry specifically directed at cytotoxic effects of F. cajanderi extracts on the Jurkat T-lymphocyte cell line (a T-cell ALL model) is documented in the secondary literature as a research objective, with Jurkat cells described as a line of T-lymphocytic leukemia cells of relevance to precursor T lymphoblastic leukemia research. However, no publication with completed results from this study was identified in the peer-reviewed literature searched.

5.2 Anti-Inflammatory Activity

Evidence level: Preclinical (in vitro); no human trials.

As described above, the aqueous extract's inhibition of TNF in LPS-stimulated monocytes in vitro represents the only direct anti-inflammatory evidence for F. cajanderi specifically. Genus-level evidence for anti-inflammatory mechanisms via NO, PGE2, iNOS, and COX-2 pathways is robust across related species such as F. pinicola and others, but species-specific confirmation for F. cajanderi has not been published in full peer-reviewed form.

5.3 Antimicrobial Activity

Evidence level: Highly preliminary; largely genus-level inference.

Laboratory studies have revealed that extracts from this fungus possess promising antioxidant and antimicrobial properties. The class of 24-methylene-lanostane triterpenes isolated from Fomes cajanderi has demonstrated antimicrobial activity in the broader literature. The fomlactone-class compounds, by analogy with other lanostane triterpenoids from related species, have been associated with antimicrobial properties in the genus. Direct antimicrobial assay data specific to F. cajanderi extracts were not identified in the primary peer-reviewed literature.

5.4 Antioxidant Activity

Evidence level: Preliminary; referenced but not fully characterized for this species.

Compounds from Fomitopsis species exhibit antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory properties, with promising applications in cancer therapy, cardiovascular health, and immune modulation. Antioxidant activity for F. cajanderi specifically is mentioned in the supplement literature but no primary quantitative antioxidant assay study (e.g., DPPH, FRAP, ORAC data) directly for F. cajanderi was identified in peer-reviewed sources.

5.5 Summary Table of Evidence Strength

• Anticancer / cytotoxic (in vitro): One conference abstract (2021) showing in vitro cytotoxicity on MCF7 and U-937 cell lines; hypothesis-generating only.
• TNF / anti-inflammatory (in vitro): One conference abstract (2021) showing beta-glucan-mediated TNF inhibition in cell culture; no animal or human data.
• Antimicrobial (in vitro, genus-level): The lanostane triterpenoid class isolated from the species has documented antimicrobial properties in related species; no dedicated assay for F. cajanderi identified.
• Antioxidant: Referenced at the genus level; no published primary data specific to F. cajanderi identified.
• Human / clinical trials: None identified in any area of use.

6. Body Systems and Health Areas Associated with Fomitopsis cajanderi

Based on the available preclinical evidence and genus-level literature, the following body systems and health areas have been investigated or discussed in connection with F. cajanderi:

• Immune system: The aqueous extract's beta-glucan content has been linked to immunomodulatory effects, with demonstrated inhibition of TNF secretion in stimulated monocytes.
• Oncology (experimental): The study aimed to determine if extracts are cytotoxic to human cancer cell lines. Both the mammary adenocarcinoma (MCF7) and histiocytic lymphoma (U-937) models were studied.
• Inflammatory pathways: Hot ethanol and aqueous extracts were studied for their cytotoxic effects on human cancer cell lines and modulation of TNF secretion.
• Wound healing / integumentary: Topical applications of dried or powdered fruiting bodies to wounds and cuts were employed in traditional indigenous practice.
• Respiratory: Infusions and decoctions made from the fruiting bodies were occasionally consumed to address respiratory issues such as coughs and sore throats, according to traditional accounts. No scientific evidence is available to support this use.
• Digestive system: Some traditions employed it as a mild digestive aid and general tonic. No scientific evidence is available to support this use.

7. Dosage Forms and Reported Dosages

No human clinical trial dosage data exist for F. cajanderi, as no such trials have been conducted. The following preparation details are drawn exclusively from the experimental literature:

• Hot ethanol extract (Soxhlet method): Made via a 2-hour Soxhlet extraction of F. cajanderi fruiting body in ethanol using a cold finger condenser. Used at increasing concentrations in vitro; specific concentrations used in the XTT cytotoxicity assay are not disclosed in the abstract.
• Hot aqueous extract (decoction): Made via a 2-hour decoction in water at 100°C. Used at increasing concentrations to assess both cytotoxicity and TNF modulation in cell culture.
• Traditional preparations: Infusions and decoctions made from the fruiting bodies were occasionally consumed in traditional practice. No standardized doses or preparation methods are documented in the ethnobotanical record for this species specifically.

No standardized dosage, extract ratio, or minimum effective or maximum tolerated dose has been established for any form of F. cajanderi in the peer-reviewed or regulatory literature. No pharmacopoeial monograph for this species was identified.

8. Safety Considerations and Interactions

8.1 Edibility Status

The fruiting body is classified as inedible. This is a standard mycological classification indicating that the fungus is not consumed as food in conventional culinary contexts, reflecting its tough, woody texture and taste profile. The inedibility classification does not by itself constitute a safety determination regarding concentrated extracts.

8.2 Absence of Clinical Safety Data

No toxicology studies, adverse event data, or safety trials specifically for F. cajanderi or its extracts were identified in peer-reviewed sources. Because no human or formal animal toxicity studies exist in the published literature for this species, its safety profile at any dose in humans is entirely unknown based on available evidence.

8.3 Genus-Level Safety Considerations

For the broader Fomitopsis genus, although bioactivity studies for disease treatment have been performed, most species have not been highly recognized to be of pharmaceutical importance for the treatment of the diseases studied and are not approved by the FDA. For use as a dietary supplement or nutraceutical, more research is needed before strong consideration for use as a supplement, as some species have been reported to show toxicity if consumed in excess of recommended established doses.

8.4 Differential Biological Activity of Extract Types

The Wenner et al. (2021) preclinical study is relevant to safety in demonstrating that the ethanol extract and the aqueous extract of F. cajanderi behave differently on the same cell populations. The hot ethanol extract induced concentration-dependent cytotoxicity of MCF7 and U-937 cells, with stronger U-937 tumoricidal effects, while the hot aqueous extract was not cytotoxic to MCF7 cells but had cytotoxic effects on undifferentiated U-937 cells at high concentrations. This finding underscores that different extraction solvents produce preparations with distinctly different biological activity profiles, with potential relevance to both therapeutic and safety considerations at higher doses.

8.5 Drug Interactions

No published pharmacokinetic or drug interaction studies involving F. cajanderi were identified. Beta-glucans from related fungal species have been studied in the context of immune modulation; TNF inhibition demonstrated in vitro by the aqueous extract of F. cajanderi is theoretically relevant to individuals taking immunosuppressive or immunomodulatory medications, but no clinical interaction data exist for this species.

8.6 Taxonomic Misidentification Risk

F. cajanderi (as Rhodofomes cajanderi) is morphologically similar to its relative Rhodofomes roseus, and other similar species include Fomitopsis pinicola, Ganoderma lucidum, G. oregonense, and Rhodonia placenta. Misidentification during wild collection represents a practical risk, as these species have distinct bioactive profiles. Correct species identification is essential in research and in any wild-harvested supplement context.

9. Research Gaps and Current State of Knowledge

The scientific literature on Fomitopsis cajanderi specifically — as distinct from the broader genus — remains at an early, exploratory stage. As of the literature available, there is not yet extensive research on Fomitopsis cajanderi as a distinct medicinal species, though research on related members of the genus, particularly F. pinicola and F. nigra, is more developed. The primary areas demanding further work include:

• Full phytochemical profiling of the fruiting body and mycelium of F. cajanderi specifically, including structural characterization of polysaccharides and their beta-glucan subfractions.
• In vitro dose-response studies and identification of IC50 values for individual isolated compounds, particularly the fomlactones and any additional secondary metabolites from the 2006 He et al. follow-up work.
• Animal-model studies of toxicity and preliminary efficacy.
• Human clinical trials — none have been conducted to date.
• Standardization of extraction conditions and pharmacopoeial specification for any supplement applications.

References

• Frontiers in Cellular and Infection Microbiology (PMC full text): "The bioactive compounds, beneficial medicinal properties, and biotechnological prospects of Fomitopsis: a comprehensive overview" (2025)
• Frontiers in Cellular and Infection Microbiology: "The bioactive compounds, beneficial medicinal properties, and biotechnological prospects of Fomitopsis: a comprehensive overview" (2025) — full text
• Wenner CA, Froehlich OR, Sitkoff A. "Fomitopsis cajanderi extracts have differential tumoricidal actions on human MCF7 and U-937 cancer cells and inhibit TNF secretion by U-937 monocytes." The Journal of Immunology, Volume 206, Issue 1_Supplement, May 2021, Page 29.10.
• Sofrenić I et al. "Cytotoxic triterpenoids and triterpene sugar esters from the medicinal mushroom Fomitopsis betulina." Phytochemistry, 2021.
• Quang DN et al. "Lanostane triterpenoids from the inedible mushroom Fomitopsis spraguei." Phytochemistry, 2005.
• Cui BK et al. "Taxonomy and phylogeny of the brown-rot fungi: Fomitopsis and its related genera." Fungal Diversity, 2016. (source of Rhodofomes cajanderi reclassification)
• Liu S et al. "Species Diversity, Molecular Phylogeny, and Ecological Habits of Fomitopsis (Polyporales, Basidiomycota)." Frontiers in Microbiology, 2022.
• NCBI Taxonomy Browser: Rhodofomes cajanderi (P. Karst.) B.K. Cui, M.L. Han & Y.C. Dai
• GBIF Species Page: Rhodofomes cajanderi (P.Karst.) B.K.Cui, M.L.Han & Y.C.Dai
• Wikipedia: Rhodofomes cajanderi
• ScienceDirect Topics: Fomitopsis — overview
• Healing-Mushrooms.net: Fomitopsis cajanderi (secondary species reference, citing He et al. 2003, 2006)
• Reishi and Roses Botanicals: "Fomitopsis cajanderi (Rhodofomes cajanderi) — healing inquiries" (2017/2018)
• ResearchGate / Studies in Mycology: "The genus Fomitopsis (Polyporales, Basidiomycota) reconsidered" (2024)
• Fomitopsins I and J, 24-methyl-lanostane triterpenoids from fruiting bodies of the wood-rot basidiomycete Fomitopsis sp. ScienceDirect, 2018.
• Li J et al. "Secondary Metabolites of Fomitopsis betulina: Chemical Structures, Biological Activity and Application Prospects." Journal of Fungi, 2024 (PMC).
• Structural investigation and comparative cytotoxic activity of water-soluble polysaccharides from fruit bodies of the medicinal fungus quinine conk (Fomitopsis officinalis). ScienceDirect, 2020.
• Pacific Northwest Pest Management Handbooks: "Fir, Douglas and True-Stem Decays (Heart Rots)" — Fomitopsis cajanderi as Rosey Top Rot / Brown Top Rot
• Medicinal Properties and Bioactive Compounds from Wild Mushrooms Native to North America. PMC, 2021.
• IntechOpen: "Medicinal Mushroom of Potential Pharmaceutical Toxic Importance: Contribution in Phytotherapy" (2022)